help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

First published online on April 24, 2008
This version published online on May 12, 2008
Endocrine Reviews, doi:10.1210/er.2007-0029
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Final Manuscript (PDF)
Right arrow RPHR Note
Right arrow All Versions of this Article:
29/3/265    most recent
Final Manuscript
Author Manuscript
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Aguilar-Bryan, L.
Right arrow Articles by Bryan, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguilar-Bryan, L.
Right arrow Articles by Bryan, J.

Neonatal Diabetes Mellitus

Lydia Aguilar-Bryan and Joseph Bryan*

Pacific Northwest Diabetes Research Institute, Seattle, Washington 98122

* To whom correspondence should be addressed. E-mail: lbryan{at}pnri.org.

An explosion of work over the last decade has produced insight into the multiple hereditary causes of a nonimmunological form of diabetes diagnosed most frequently within the first 6 months of life. These studies are providing increased understanding of genes involved in the entire chain of steps that control glucose homeostasis. Neonatal diabetes is now understood to arise from mutations in genes that play critical roles in the development of the pancreas, of {beta}-cell apoptosis and insulin processing, as well as the regulation of insulin release. For the basic researcher, this work is providing novel tools to explore fundamental molecular and cellular processes. For the clinician, these studies underscore the need to identify the genetic cause underlying each case. It is increasingly clear that the prognosis, therapeutic approach, and genetic counseling a physician provides must be tailored to a specific gene in order to provide the best medical care.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society